Original articleMultiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J
References (22)
- et al.
Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup
Eur J Cancer
(2002) - et al.
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup
Lancet
(1997) - et al.
Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli’s 4th protocol
Eur J Cancer
(2001) - et al.
Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders
Eur J Cancer
(2003) - et al.
Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy
J Cancer Res Clin Oncol
(1983) - et al.
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity
N Engl J Med
(1986) - et al.
Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial
J Clin Oncol
(1987) - et al.
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651
J Clin Oncol
(2003) - et al.
Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity: histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor
Cancer
(2003) - et al.
Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults
Am J Clin Oncol
(2002)
Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity
Ann Surg Oncol
(2003)
Cited by (91)
Outcomes and survival rates of childhood osteosarcoma in Iran, A report from MAHAK Pediatric Cancer Treatment and Research Center, from 2007 to 2020
2023, Journal of Cancer Research and Therapeutics
Copyright © 2009 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.